The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Carcinoma, Renal Cell

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Carcinoma, Renal Cell

 

Psychiatry related information on Carcinoma, Renal Cell

 

High impact information on Carcinoma, Renal Cell

 

Chemical compound and disease context of Carcinoma, Renal Cell

 

Biological context of Carcinoma, Renal Cell

 

Anatomical context of Carcinoma, Renal Cell

 

Gene context of Carcinoma, Renal Cell

 

Analytical, diagnostic and therapeutic context of Carcinoma, Renal Cell

References

  1. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Seizinger, B.R., Rouleau, G.A., Ozelius, L.J., Lane, A.H., Farmer, G.E., Lamiell, J.M., Haines, J., Yuen, J.W., Collins, D., Majoor-Krakauer, D. Nature (1988) [Pubmed]
  2. Treatment of metastatic melanoma and renal cell carcinoma with interleukin-2. Manson, L.A. JAMA (1994) [Pubmed]
  3. Erythema nodosum in a patient with renal cell carcinoma treated with interleukin 2 and lymphokine-activated killer cells. Weinstein, A., Bujak, D., Mittelman, A., Davidian, M. JAMA (1987) [Pubmed]
  4. Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma. Sznol, M., Clark, J.W., Smith, J.W., Steis, R.G., Urba, W.J., Rubinstein, L.V., VanderMolen, L.A., Janik, J., Sharfman, W.H., Fenton, R.G. J. Natl. Cancer Inst. (1992) [Pubmed]
  5. Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone. Halmos, G., Schally, A.V., Varga, J.L., Plonowski, A., Rekasi, Z., Czompoly, T. Proc. Natl. Acad. Sci. U.S.A. (2000) [Pubmed]
  6. Interferon-related leukoencephalopathy in a patient with renal cell carcinoma. Merimsky, O., Reider, I., Merimsky, E., Chaitchik, S. Tumori. (1991) [Pubmed]
  7. Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma. Pantuck, A.J., Belldegrun, A.S., Figlin, R.A. N. Engl. J. Med. (2001) [Pubmed]
  8. Tumour suppression by the human von Hippel-Lindau gene product. Iliopoulos, O., Kibel, A., Gray, S., Kaelin, W.G. Nat. Med. (1995) [Pubmed]
  9. Gamma-glutamyltransferase in hypernephroma. Cardo, L.J. JAMA (1991) [Pubmed]
  10. Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. Tatsumi, T., Kierstead, L.S., Ranieri, E., Gesualdo, L., Schena, F.P., Finke, J.H., Bukowski, R.M., Mueller-Berghaus, J., Kirkwood, J.M., Kwok, W.W., Storkus, W.J. J. Exp. Med. (2002) [Pubmed]
  11. MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants. Kanamaru, H., Kakehi, Y., Yoshida, O., Nakanishi, S., Pastan, I., Gottesman, M.M. J. Natl. Cancer Inst. (1989) [Pubmed]
  12. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. Brauch, H., Weirich, G., Hornauer, M.A., Störkel, S., Wöhl, T., Brüning, T. J. Natl. Cancer Inst. (1999) [Pubmed]
  13. Enzymes of purine metabolism in human and rat renal cortex and renal cell carcinoma. Jackson, R.C., Goulding, F.J., Weber, G. J. Natl. Cancer Inst. (1979) [Pubmed]
  14. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. Ebina, Y., Okada, S., Hamazaki, S., Ogino, F., Li, J.L., Midorikawa, O. J. Natl. Cancer Inst. (1986) [Pubmed]
  15. Tumor-specific cell-mediated immunity in household contacts of cancer patients.. Byers, V.S., Levin, A.S., Hackett, A.J., Fudenberg, H.H. J. Clin. Invest. (1975) [Pubmed]
  16. Targeting the loss of the von Hippel-Lindau tumor suppressor gene in renal cell carcinoma cells. Sutphin, P.D., Chan, D.A., Li, J.M., Turcotte, S., Krieg, A.J., Giaccia, A.J. Cancer Res. (2007) [Pubmed]
  17. Enhanced expression of interleukin-6 in primary human renal cell carcinomas. Takenawa, J., Kaneko, Y., Fukumoto, M., Fukatsu, A., Hirano, T., Fukuyama, H., Nakayama, H., Fujita, J., Yoshida, O. J. Natl. Cancer Inst. (1991) [Pubmed]
  18. Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Hergovich, A., Lisztwan, J., Barry, R., Ballschmieter, P., Krek, W. Nat. Cell Biol. (2003) [Pubmed]
  19. Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein. Na, X., Duan, H.O., Messing, E.M., Schoen, S.R., Ryan, C.K., di Sant'Agnese, P.A., Golemis, E.A., Wu, G. EMBO J. (2003) [Pubmed]
  20. Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. de Paulsen, N., Brychzy, A., Fournier, M.C., Klausner, R.D., Gnarra, J.R., Pause, A., Lee, S. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  21. Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma. Osband, M.E., Lavin, P.T., Babayan, R.K., Graham, S., Lamm, D.L., Parker, B., Sawczuk, I., Ross, S., Krane, R.J. Lancet (1990) [Pubmed]
  22. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Whaley, J.M., Naglich, J., Gelbert, L., Hsia, Y.E., Lamiell, J.M., Green, J.S., Collins, D., Neumann, H.P., Laidlaw, J., Li, F.P. Am. J. Hum. Genet. (1994) [Pubmed]
  23. Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Finke, J.H., Zea, A.H., Stanley, J., Longo, D.L., Mizoguchi, H., Tubbs, R.R., Wiltrout, R.H., O'Shea, J.J., Kudoh, S., Klein, E. Cancer Res. (1993) [Pubmed]
  24. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment. Schendel, D.J., Gansbacher, B. Cancer Res. (1993) [Pubmed]
  25. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas. Weterman, M.A., Wilbrink, M., Geurts van Kessel, A. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  26. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Vanharanta, S., Buchta, M., McWhinney, S.R., Virta, S.K., Peçzkowska, M., Morrison, C.D., Lehtonen, R., Januszewicz, A., Järvinen, H., Juhola, M., Mecklin, J.P., Pukkala, E., Herva, R., Kiuru, M., Nupponen, N.N., Aaltonen, L.A., Neumann, H.P., Eng, C. Am. J. Hum. Genet. (2004) [Pubmed]
  27. Expression of the von Hippel-Lindau-binding protein-1 (Vbp1) in fetal and adult mouse tissues. Hemberger, M., Himmelbauer, H., Neumann, H.P., Plate, K.H., Schwarzkopf, G., Fundele, R. Hum. Mol. Genet. (1999) [Pubmed]
  28. A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma. Wilson, C., Idziaszczyk, S., Parry, L., Guy, C., Griffiths, D.F., Lazda, E., Bayne, R.A., Smith, A.J., Sampson, J.R., Cheadle, J.P. Hum. Mol. Genet. (2005) [Pubmed]
  29. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Kuiper, R.P., Schepens, M., Thijssen, J., van Asseldonk, M., van den Berg, E., Bridge, J., Schuuring, E., Schoenmakers, E.F., van Kessel, A.G. Hum. Mol. Genet. (2003) [Pubmed]
  30. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Horikawa, Y., Wood, C.G., Yang, H., Zhao, H., Ye, Y., Gu, J., Lin, J., Habuchi, T., Wu, X. Clin. Cancer Res. (2008) [Pubmed]
  31. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas. Fritzsche, F.R., Oelrich, B., Johannsen, M., Kristiansen, I., Moch, H., Jung, K., Kristiansen, G. Clin. Cancer Res. (2008) [Pubmed]
  32. CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression. Dörrschuck, A., Schmidt, A., Schnürer, E., Glückmann, M., Albrecht, C., Wölfel, C., Lennerz, V., Lifke, A., Di Natale, C., Ranieri, E., Gesualdo, L., Huber, C., Karas, M., Wölfel, T., Herr, W. Blood (2004) [Pubmed]
  33. Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies? Neumann, E., Engelsberg, A., Decker, J., Störkel, S., Jaeger, E., Huber, C., Seliger, B. Cancer Res. (1998) [Pubmed]
  34. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models. Kadhim, S.A., Bowlin, T.L., Waud, W.R., Angers, E.G., Bibeau, L., DeMuys, J.M., Bednarski, K., Cimpoia, A., Attardo, G. Cancer Res. (1997) [Pubmed]
  35. Treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2: a single-center phase II study. Geertsen, P.F., Hermann, G.G., von der Maase, H., Steven, K. J. Clin. Oncol. (1992) [Pubmed]
  36. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Patel, N.S., Li, J.L., Generali, D., Poulsom, R., Cranston, D.W., Harris, A.L. Cancer Res. (2005) [Pubmed]
 
WikiGenes - Universities